0

Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

  • 작성자한진
  • 작성일2008-06-08 13:16:45
  • 조회수4012
  • 첨부파일첨부파일
http://www.news-medical.net/?id=37738 Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB target gene expression in atrial tissue. Their study will appear in the May 08 issue of Experimental Biology and Medicine. Multiple tachycardia-associated factors appear to contribute to this response, which all are directly or indirectly linked to oxidative stress. Accordingly, blockade of the angiotensin II type 1 receptor, inhibition of L-type calcium channels, inhibition of NADPH oxidase, applications of antioxidants, and inhibition of NF-?? activation were all found to abolish or decrease the tachycardia-dependent changes in the atrial tissue. The interdisciplinary research team, led by Uwe Lendeckel, a professor of Experimental Internal Medicine and Andreas Goette, Deputy Chief of Cardiology, designed the study to determine the influence of tachyarrhythmia on endocardial dysfunction (called endocardial remodelling) and to decipher the molecular mechanism(s) that translate pathologically increased heart rates into myocardial/endocardial dysfunction. Endocardial dysfunction appears as a well recognised risk factor for thromboembolic events in patients with atrial fibrillation (AF). Therefore, the underlying pathophysiology of endocardial remodelling is of clinical importance. "The facts that equal results were observed in ex vivo atrial tissue from patients with AF and in ex vivo rapidly paced tissue samples from patients with sinus rhythm (SR), together with the observation that verapamil most potently prevented oxidative stress and associated signalling pathway activation, led us to conclude that the elevated frequency per se and concomitant Ca2+-overload precede and induce mitochondrial dysfunction and oxidative stress in AF" said Lendeckel. Goette added "Our results have several clinical implications. Atrial ischemia produces an increase in cellular calcium load and oxidative stress in the atria. Thereby, atrial ischemia provides a specific substrate for AF. Recent experimental and clinical data showed that calcium channel blockers have a specific efficacy to prevent AF in this specific situation. Thus, our data provide more information about the potential pathophysiologic mechanism explaining why calcium channel blockers are effective and useful to attenuate atrial cellular remodelling especially under conditions of increased cellular calcium load and oxidative stress". The authors say " the use of ex vivo human atrial tissue from patients with and without AF as well as the rapid pacing of atrial tissue slices to mimic AF ex vivo is a valuable approach to identify molecular and cellular effects that are solely due to the AF excluding the effects of concomitant cardiac diseases." Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "Professor Lendeckel, Professor Goette and colleagues have demonstrated that inward calcium current via L-type calcium channels contributes to oxidative stress and increased expression of oxidative stress markers and adhesion molecules during cardiac tachyarrhythmia.". He further stated "These observations are important to the understanding of the molecular mechanisms by which calcium overload and resulting mitochondrial dysfunction and resulting oxidative stress impact atrial remodelling during atrial fibrillation." Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. http://www.sebm.org
Total406 [ page6/28 ]
No. 제목 작성자 작성일 조회수
331 심장 비대와 연관된 새로운 세포 경로 규명 첨부파일 2009.03.03 홍다혜 2009.03.03 3,713
330 줄기세포연구과정에서 발견한 제2형 당뇨병의 기작 2009.02.26 한진 2009.02.26 2,456
329 심근세포의 증식(hyperplasia) 또는 비대(hypertrophy)를 결정하는 스위치: 심장섬유모세포(cardiac fibroblasts) 2009.02.26 한진 2009.02.26 3,114
328 경남매일에도 김형규쌤 상받는 올랐네요 2009.02.25 최성우 2009.02.25 2,023
327 인제학술대상에 의학과 박사과정 김형규 씨가 수상의 영광 첨부파일 2009.02.20 한진 2009.02.20 2,119
326 site link : National Institue of Health 2009.02.16 최성우 2009.02.16 1,657
325 세계 생리학회 개최, 2009년 2월호 인제대소식지에 실렸습니다 2009.02.10 최성우 2009.02.10 1,897
324 폐경기 여성의 심장 박동수 측정을 통한 심혈관 질환 발병 가능성 예측 첨부파일 2009.02.09 홍다혜 2009.02.09 2,395
323 심장비대를 줄여주는 신약의 개발 첨부파일 2009.02.08 홍다혜 2009.02.08 2,063
322 골다공증 일으키는 새 메커니즘 찾았다! 2009.02.05 홍다혜 2009.02.05 1,817
321 알츠하이머,치매 = 제3형 당뇨병? 2009.02.03 홍다혜 2009.02.03 2,088
320 콘드로이틴, 무릎 골관절염 진행을 지연시키고 증상을 완화 2009.02.02 홍다혜 2009.02.02 1,896
319 유신선생 논문, 축하해주세요. 2009.01.23 한진 2009.01.23 2,209
318 국내연구진, 비만·당뇨·지방간 치료약물 개발 2009.01.22 한진 2009.01.22 2,295
317 [매일경제 등등] 인제대, 15~17일 세계 생리학 학술대회 관련기사 2009.01.20 최성우 2009.01.20 1,922
처음이전 1 2 3 4 5 6 7 8 9 10 다음 마지막